Toxoplasmosis

Toxoplasmosis is a parasitic infection caused by Toxoplasma gondii, a protozoan parasite cited in the provided literature as relevant to public health surveillance ^[1][2]. The available sources frame the condition across several clinical contexts, including congenital toxoplasmosis, postnatally acquired disease, and ocular toxoplasmosis ^[1][3]. A historical citation also notes that toxoplasmosis has multiple clinical manifestations in humans, but the present source set does not supply a more formal etiologic or taxonomic summary ^[2].

The clearest syndrome described in the sources is ocular toxoplasmosis, which is identified as one of the most frequent infectious causes of posterior uveitis and typically presents with retinochoroiditis ^[3]. The ocular review emphasizes that diagnosis depends heavily on recognizing characteristic clinical features and that parasitic DNA detection in aqueous or vitreous humor can support definitive diagnosis, but detailed clinical course beyond vision-threatening potential is not expanded in the snippet ^[3]. Broader sources note that toxoplasmosis has various clinical manifestations in humans and has been discussed in relation to congenital disease, immunocompromised hosts, and latent infection with neuropsychiatric associations ^[2][1]. Source-backed detail on fever, lymphadenopathy, neurologic syndromes, or complication frequency is not yet available in the supplied material ^[3][1].

Within the supplied evidence, ocular toxoplasmosis is highlighted as a common infectious cause of posterior uveitis, indicating clinical relevance in eye-disease surveillance ^[3]. A separate review states that toxoplasmosis has traditionally been considered important in congenital infection and in postnatally acquired disease among immunocompromised patients, while also noting emerging associations between latent infection and a wide variety of neuropsychiatric disorders ^[1]. The source set does not provide geographic distribution, outbreak patterns, animal reservoir detail, or burden estimates, so those features cannot be stated here ^[3][1].

The provided sources do not describe a complete transmission pathway for toxoplasmosis ^[3][1]. They do indicate postnatally acquired disease and latent infection, but do not specify the exposure mechanisms by which infection is acquired in the supplied text ^[3][1]. Source-backed detail on foodborne, environmental, congenital, or other transmission routes is not yet available in this payload ^[3][1].

The sources specifically identify congenital contexts and postnatally acquired disease in immunocompromised patients as traditionally important public-health settings for toxoplasmosis ^[1]. Ocular toxoplasmosis is also emphasized as an important clinical form, but the supplied text does not define demographic or occupational risk strata ^[3]. Source-backed detail on pregnancy, age-specific vulnerability, or other high-risk exposures is not yet available in the current material ^[3][1].

The clearest preventive implication in the sources is that improved diagnostic and therapeutic approaches for ocular toxoplasmosis may help prevent or limit vision loss ^[3]. Beyond this, the supplied material does not provide exposure-control measures, prophylaxis recommendations, or vaccine information ^[3][1]. Any broader prevention guidance would require evidence not present in the current source set ^[3][1].

For surveillance purposes, toxoplasmosis should be read as a heterogeneous parasitic infection concept rather than a single syndrome, with the strongest source support here for ocular disease and broader relevance to congenital and immunocompromised-host disease ^[3][1]. The literature also suggests that latent infection may have public-health significance beyond overt clinical toxoplasmosis, but the current payload does not quantify that contribution ^[1]. Because the source set lacks standardized incidence, geographic, and transmission data, monitoring should remain cautious and restricted to source-supported clinical categories ^[3][1].

1. 1 Milne G et al. Toxoplasma gondii: AnUnderestimated Threat? Trends Parasitol. 2020 Dec. PMID: 33012669. doi: 10.1016/j.pt.2020.08.005. PubMed: https://pubmed.ncbi.nlm.nih.gov/33012669/
2. 2 Toxoplasmosis. Journal of Small Animal Practice. 1963. doi: 10.1111/j.1748-5827.1963.tb01300.x. DOI: https://doi.org/10.1111/j.1748-5827.1963.tb01300.x
3. 3 Kalogeropoulos D et al. Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Int Ophthalmol. 2022 Jan. PMID: 34370174. doi: 10.1007/s10792-021-01994-9. PubMed: https://pubmed.ncbi.nlm.nih.gov/34370174/
4. 4 Bodilsen J et al. European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults. Clin Microbiol Infect. 2024 Jan. PMID: 37648062. doi: 10.1016/j.cmi.2023.08.016. PubMed: https://pubmed.ncbi.nlm.nih.gov/37648062/
5. 5 Toxoplasmosis. FRCR 2B Viva: A Case-Based Approach. 2013. doi: 10.1055/b-0034-79013. DOI: https://doi.org/10.1055/b-0034-79013
6. 6 Toxoplasmosis. Annals of Internal Medicine. 1972. doi: 10.7326/0003-4819-77-5-773. DOI: https://doi.org/10.7326/0003-4819-77-5-773

ICD-10

B58

ICD-11

1F57

Total cases

0

Peak month

—

Coverage

0 reporting countries · —